Premium Technology and Facilities

HealthBanks uses top of the line premium technology to help retrieve and preserve the most viable stem cells for future use.

Our Advanced Processing and Storage Technologies

FDA Approved Sterile Collection Bags

CPD collection bags help keep cord blood viable for 48 hours after collection

Learn More

AXP® Processing System

The automated AXP® Processing System allows us to obtain the highest number of stem cells from your child’s cord blood.

Learn More

BioArchive® Cryopreservation System

The BioArchive® System allows for optimal storage of your child’s stem cells, maintaining the viability for the day you need them.

Learn More

FDA Approved Sterile Collection Bags

HealthBanks uses the only FDA approved sterile (and Heparin free) collection bag for use in C-sections. Using this FDA approved sterile collection bag is necessary to maintain a sterile operating room. Furthermore, HealthBanks uses the FDA and NDA approved anticoagulant Citrate Phosphate Dextrose Solution* (CPD), a cell protector, also recommended by the Department of Health and Human Services, Center for Biologics Evaluation and Research, Guidance for Industry.**

CPD preserves stem cell metabolism, unlike Heparin, allowing the cells to maintain their integrity between the time of collection to processing, as well as result in a significantly higher total nuclear cell count (TNC) before and after cord blood processing.***

FDA Approved Sterile Collection Bags

HealthBanks uses the only FDA approved sterile (and Heparin free) collection bag for use in C-sections. Using this FDA approved sterile collection bag is necessary to maintain a sterile operating room. Furthermore, HealthBanks uses the FDA and NDA approved anticoagulant Citrate Phosphate Dextrose Solution* (CPD), a cell protector, also recommended by the Department of Health and Human Services, Center for Biologics Evaluation and Research, Guidance for Industry.**

CPD preserves stem cell metabolism, unlike Heparin, allowing the cells to maintain their integrity between the time of collection to processing, as well as result in a significantly higher total nuclear cell count (TNC) before and after cord blood processing.***

*HealthBank’s collection bag containing CPD is FDA NDA approved and CE marked under the Medical Devices Directive for the collection of placental/umbilical cord blood. https://www.pall.com/medical_41560.asp

** During collection of cord blood, we recommend that you use an appropriate closed, sterile container sealed in a manner that prevents cell loss and contamination. We recommend that you use only citrate-based anticoagulants.” U.S. Dept of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, Guidance for Industry – Minimally Maninpulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hemapoietic Reconstitution for Specified Indications, October 2009

***Blood (ASH Annual Meeting Abstracts) American Society of Hematology “Cord Blood Units Collected with Liquid CPD Appear to Contain Significantly More Nucleated and CD34+ Cells Than Units Collected with Dry Heparin” Morey Kraus*,1, Karen Foster*,2, AsimenaRigas Bridges*,3 and Mark C. Walters, MD 4 2009 114: Abstract 4227
https://abstracts.hematologylibrary.org/cgi/content/abstract/114/22/4227

AXP® System Processing

At HealthBanks, we rely on the FDA cleared AXP® Processing System — a fully automated closed and automated system that consistently and efficiently processes stem cells from umbilical cord blood. Studies show that the AXP® extracts the greatest number of stem cells from any given sample. Thanks to hands-free operation, the system delivers sterile, precise performance-which means more of your stem cells get preserved and without extra contaminants, like excess red blood cells, which are known to cause complication at the time of transplant. This system is used only by the most prestigious cell banks in the world and more than 1,000,000 automated processing procedures have been performed worldwide.

BioArchive® Storage System

Parents often ask us “How long will our baby’s stem cells last?” An excellent question, as it leads to the importance of freezing and storage technology. At HealthBanks, we rely on the BioArchive® Cryopreservation technology that uses a fully automated and robotic controlled storage system designed specifically for the tracking, retrieval, and long term storage of stem cells and immune cells. HealthBanks, along with the world’s leading public cord blood banks, uses the BioArchive® System because it is a leading platform that has been used for storing cell therapies known as BLAs (Biological License Applications), such as cord blood samples approved by the FDA. Most other cell banks instead use Dewar tank technology, which has risk to exposure and contamination. This is one of many advantages of BioArchive® over traditional systems used for cryopreservation and long term cord blood stem cell storage.

Viable CD34+ stem cell recovery is consistently above 97%, a much higher percentage than other available systems. The importance of freezing and storing cord blood stem cells undisturbed and under liquid nitrogen at -196º C for long-term viability is emphasized in the Guidelines for Collection, Processing and Storage of Cord blood stem cells published by the New York State Department of Health, as well as by published studies by the New York Blood Center, the nation’s oldest and largest public cord blood bank.*

BioArchive® System

Parents often ask us “How long will our baby’s stem cells last?” An excellent question, as it leads to the importance of freezing and storage technology. At HealthBanks, we rely on the BioArchive® Cryopreservation technology which is designed specifically for the tracking, retrieval, and long term storage of cord blood stem cells. HealthBanks, along with the world’s leading public cord blood banks, uses the BioArchive® System because it offers distinct advantages over traditional systems used for cryopreservation and long term cord blood stem cell storage.

In fact, the importance of freezing and storing cord blood stem cells undisturbed and under liquid nitrogen at -196º C for long-term viability is emphasized in the Guidelines for Collection, Processing and Storage of Cord blood stem cells published by the New York State Department of Health, as well as by published studies by the New York Blood Center, the nation’s oldest and largest public cord blood bank.*

GMP clean room for optimal protection & safety of Stem Cells.

licensed State of California Department of Health and AABB accredited facility

FDA registered and inspected and standing member of the Irvine Chamber of Commerce.

Rest assured your baby’s Stem Cells are stored safe and sound with HealthBanks.

At HealthBanks, we are focused on what truly matters when it comes to the long term health and viability of your baby’s stem cells: state-of-the art automated cord banking technology, rapid collection and freezing, and personal service.

Subscribe to Our Newsletter & Special Promotions

Disclaimer: The use of cord blood and immune cells is determined by the treating physician and manufacturer of the final products and is influenced by many factors, including the patient's medical condition, the characteristics of the sample, and whether the immune cells should be further modified or expanded. Cord blood has established uses in transplant medicine; however, its use in regenerative medicine is still being researched. There is no guarantee that potential medical applications being studied in the laboratory or clinical trials will become available. Cord tissue use is still in early research stages, and there is no guarantee that treatments using cord tissue will be available in the future. Cord tissue is stored whole. Additional processing prior to use will be required to extract and prepare any of the multiple cell types from cryopreserved cord tissue. Immune cells has established uses in certain blood cancer treatment; however, its use in solid cancer is still being researched. There is no guarantee that treatments being studied in the laboratory, clinical trials, or other experimental treatments will be available in the future.

HealthBanks cryopreserves immune cells that have been collected from an individual for potential future cellular therapy use. HealthBanks does not provide medical advice, treatment or care. The use of cryopreserved cells for future immunotherapies is not guaranteed. Much is yet unknown about the future of immunotherapy and the immune cells that have been cryopreserved. The use of cryopreserved cells by commercial manufacturers for CAR-T therapy production is not currently approved by the FDA. There is active research ongoing, however, there is no guarantee that your cryopreserved cells will have a future therapeutic use. Only your health care professional can help you evaluate whether your cells might be used and if so, how they might be used. HealthBanks and its shareholders, directors, officers, agents, employees, affiliates, network of providers and provider facilities, will not be liable to you or any other party for claims relating to sample collection or if your cells cannot be used, or if any harm, injury, damage or loss results from the use of your cells. For more information, please refer to HealthBanks Service Agreement.